# C4 Therapeutics, Inc.: Form 8-K, filed May 4, 2023

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2023-05-04
- Accepted by EDGAR: May 4, 2023, 07:34 ET
- Period: 2023-05-04
- Accession: 0001628280-23-015454
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828023015454/cccc-20230504.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828023015454/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828023015454/cccc-20230504.htm

Filed May 4, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-015454. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.